6.98
-0.11 (-1.55%)
| Penutupan Terdahulu | 7.09 |
| Jumlah Dagangan | 96,924 |
| Harga / Jualan (P/S) | 2.12 |
| Harga / Buku (P/B) | 5.84 |
| Julat 52 Minggu |
| Margin Keuntungan | -99.17% |
| Margin Operasi (TTM) | -11.05% |
| EPS Cair (TTM) | -4.86 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 33.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 14.02% |
| Nisbah Semasa (MRQ) | 1.81 |
| Aliran Tunai Operasi (OCF TTM) | -3.91 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 19.59 M |
| Pulangan Atas Aset (ROA TTM) | -6.31% |
| Pulangan Atas Ekuiti (ROE TTM) | -304.05% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | LENSAR, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.79 |
|
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 19.64% |
| % Dimiliki oleh Institusi | 44.03% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |